๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐๐ญ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐๐ฌ ๐๐จ๐ซ ๐ช๐ฎ๐๐ฅ๐ข๐ญ๐ฒ ๐๐จ๐ง๐ญ๐ซ๐จ๐ฅ ๐จ๐ ๐ฆ๐๐๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ?
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐๐ญ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐๐ฌ ๐๐จ๐ซ ๐ช๐ฎ๐๐ฅ๐ข๐ญ๐ฒ ๐๐จ๐ง๐ญ๐ซ๐จ๐ฅ ๐จ๐ ๐ฆ๐๐๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ?
Access Thomas Menneteauโs presentation on ๐๐ฎ๐ฅ๐ญ๐ข๐ฉ๐ฅ๐ ๐๐ญ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ ๐๐จ๐ง๐ข๐ญ๐จ๐ซ๐ข๐ง๐ ๐๐จ๐ซ ๐ฆ๐๐๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ to find out ๐ฝ
https://lnkd.in/eqTCd2Gx
๐ธ Determination of 5โ cap identity and percentage
๐ธ Determination of polyA tail length distribution
๐ธ Case studies: analysis of a drug substance and product
๐ Explore our complete analytical package for mRNA-based therapeutics: https://lnkd.in/e98dKHB
๐ค Get in touch with us: https://lnkd.in/dNy3QdF
๐ Waters Corporation Biopharma Seminar Day
#MAM #mRNA